Rockwell Medical, Inc. (RMTI)
NASDAQ: RMTI · Real-Time Price · USD
1.180
-0.010 (-0.84%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Rockwell Medical Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Rockwell Medical stock have an average target of 4.00, with a low estimate of 3.00 and a high estimate of 5.00. The average target predicts an increase of 238.98% from the current stock price of 1.18.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 24, 2025.
Analyst Ratings
The average analyst rating for Rockwell Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $7 → $3 | Strong Buy | Maintains | $7 → $3 | +154.24% | Mar 24, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +493.22% | Dec 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $7 | Strong Buy | Maintains | $9 → $7 | +493.22% | Nov 25, 2024 |
Rodman & Renshaw | Rodman & Renshaw | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +323.73% | Nov 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +662.71% | Sep 11, 2024 |
Financial Forecast
Revenue This Year
68.77M
from 101.49M
Decreased by -32.24%
Revenue Next Year
75.94M
from 68.77M
Increased by 10.42%
EPS This Year
-0.17
from -0.03
EPS Next Year
-0.14
from -0.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 73.3M | 84.6M |
Avg | 68.8M | 75.9M |
Low | 63.7M | 66.9M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | -27.8% | 23.1% |
Avg | -32.2% | 10.4% |
Low | -37.2% | -2.7% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | -0.11 | -0.06 |
Avg | -0.17 | -0.14 |
Low | -0.23 | -0.21 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.